Next Generation Gene Therapeutics is based in California. It has raised $30M in total funding. Latest round: Series A.
Next Generation Gene Therapeutics is based in California. Next Generation Gene Therapeutics has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2021. The round record for Next Generation Gene Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Kington Capital, Weidu Capital, Northern Light Venture Capital, YuanBio Venture Capital. 4 distinct backers are named across the disclosed rounds.
We update the Next Generation Gene Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in California and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026